AI Tool for Radiotherapy Can Support the Global Effort to Eliminate Cervical Cancer

Why It Matters

Automating complex treatment planning can dramatically expand curative radiotherapy reach in underserved regions, potentially saving millions of lives, while also boosting efficiency in high‑income health systems.

Key Takeaways

• AI achieved >95% high‑quality plans for cervical cancer in ARCHERY trial
• Planning time cut from weeks to ~1 hour, easing specialist bottlenecks
• Trial spanned four low‑ and middle‑income countries, over 1,000 patients
• Prostate cancer plans met high standards in 85% of cases
• Scalable AI could help WHO meet cervical cancer elimination targets

Pulse Analysis

Cervical cancer remains a stark global health inequity, with 94% of the 350,000 deaths in 2022 occurring in low‑ and middle‑income nations. Radiotherapy, the cornerstone curative modality, is under‑utilized because only about 10% of patients in low‑income countries receive it, largely due to a shortage of trained oncologists and physicists. By automating the intricate contouring and beam‑configuration steps, AI offers a way to bridge this workforce gap, turning a resource‑intensive process into a rapid, reproducible workflow that can be deployed wherever a linear accelerator exists.

The ARCHERY trial, coordinated by UCL and LSHTM, provided the first large‑scale, multi‑country evidence of such technology’s clinical viability. Over 1,000 participants with cervical, prostate and head‑and‑neck cancers were treated in hospitals across India, South Africa, Jordan and Malaysia. The AI system produced plans meeting international best‑practice standards in more than 95% of cervical cases and 85% of prostate cases, with expert review confirming suitability for routine use. Crucially, the planning duration collapsed from multi‑week timelines to just over an hour, freeing specialist time for patient care and potentially slashing waiting lists.

Beyond immediate clinical gains, the trial’s results have policy implications. They bolster the WHO’s cervical cancer elimination strategy, which hinges on scaling treatment capacity alongside vaccination and screening. Health ministries can now consider AI‑assisted planning as a cost‑effective lever to maximize existing radiotherapy infrastructure, especially in settings where purchasing additional machines is prohibitive. As AI adoption spreads, future work will need to address data privacy, algorithmic bias, and integration with local treatment protocols, but the evidence suggests a transformative opportunity to democratize life‑saving cancer care worldwide.